Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage

Rheumatology

Volumn 41, Issue 7, 2002, Pages 801-808

  Mastbergen, S C ^a   Lafeber, F P J G ^a   Bijlsma, J W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Human cartilage tissue; IL 1 ; Inflammation; Proteoglycan turnover; Selective COX 2 inhibitor; TNF

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CARTILAGE MATRIX; COCULTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; TURNOVER TIME;

AGED; CARTILAGE, ARTICULAR; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLOOXYGENASE INHIBITORS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; MALE; PROTEOGLYCANS; PYRAZOLES; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0036319011     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Rheumatoid arthritis. Pathophysiology and implications for therapy
2. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2
3. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
4. Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation
5. Role of inducible cyclooxygenase (COX-2) in inflammation
6. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
7. COX-1 and COX-2 tissue expression: Implications and predictions
8. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin
9. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
10. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
11. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs
12. The advent of highly selective inhibitors of cyclooxygenase - A review
13. Celecoxib, COX-2-specific inhibitor: The clinical data
14. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin
15. Cox-2 inhibitors
16. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors
17. Selective cyclooxygenase-2 inhibitors for the treatment of arthritis
18. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
19. Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro
20. Nonsteroidal anti-inflammatory drugs: Effects on normal and interleukin 1 treated human articular chondrocyte metabolism in vitro
21. Comparison of the effects of non-steroidal anti-inflammatory drugs (NSAIDs) on proteoglycan synthesis by articular cartilage explant and chondrocyte monolayer cultures
22. Mechanisms of action of anti-inflammatory medications used for the treatment of osteoarthritis
23. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: Differential elevation of cyclooxygenase 2 in inflammatory joint diseases
24. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis
25. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage
26. Stimulation by prostaglandin F2alpha of acidic glycosaminoglycan production in cultured fibroblasts
27. Effect of prostaglandin E2 on adult pig articular cartilage slices in culture
28. Degenerated human articular cartilage at autopsy represents preclinical osteoarthritic cartilage: Comparison with clinically defined osteoarthritic cartilage
29. Blood-induced joint damage: A human in vitro study
30. The stimulation of mononuclear cells from patients with rheumatoid arthritis to degrade articular cartilage is not modulated by cartilage itself
31. Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers
32. Articular cartilage explant culture: An appropriate in vitro system to compare osteoarthritic and normal human cartilage
33. Human osteoarthritic cartilage is synthetically more active but in culture less vital than normal cartilage
34. The quantitative measurement of Alcian Blue-glycosaminoglycan complexes
35. Inhibition of cartilage proteoglycan synthesis by interleukin I
36. Interleukin-1 inhibits keratan sulfate production by rabbit chondrocytes: Possible role of prostaglandin E2
37. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage
38. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis expression
39. Cartilage maintenance in osteoarthritis: Interaction of cytokines, NSAID and prostaglandins in articular cartilage damage and repair
40. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?
41. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis
42. The effects of NSAID on the matrix of human articular cartilages
43. The effect of nonsteroidal antiinflammatory drugs on human articular cartilage glycosaminoglycan synthesis
44. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2
45. Prevention of spontaneous polyarthritis in NZB/KN mice by treatment with a novel thiazole derivative, SM-8849
46. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
47. Nonsteroidal anti-inflammatory drugs in treatment of osteoarthritis
48. The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the rat
49. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis
50. Influence of interleukin-1 beta, tumour necrosis factor alpha and prostaglandin E2 on chondrogenesis and cartilage matrix breakdown in vitro
51. Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro
52. Role of intestinal epithelial cells in the host secretary response to infection by invasive bacteria. Bacterial entry induces epithelia] prostaglandin H synthase-2 expression and prostaglandin E2 and F2alpha production
53. The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(-/-), but not in cyclooxygenase-1 (-/-) mice
54. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection
55. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2
56. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease
57. Inhibitory and stimulating effects of Prostaglandins A, E, F on the in vitro biosynthesis of glycosaminoglycans and protein from calf rib cartilage
58. The effect of prostaglandins on in vitro limb cartilage differentiation
59. The effect of prostaglandins of cultured lapine articular chondrocytes
60. Correlation of the biosynthesis of prostaglandin and cyclic AMP in monolayer cultures of rabbit articular chondrocytes
61. Effects of anti-inflammatory drugs on prostaglandins in rheumatoid arthritis
62. Prostaglandin concentration in synovial fluid in rheumatic diseases: Action of indomethacin and aspirin
63. Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis
64. Immunohistochemical localization of prostaglandin E in rheumatoid synovial tissues
65. Human synovium releases a factor which stimulates chondrocyte production of PGE and plasminogen activator